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ABSTRACT 
The purpose of the Multi-Center Study Investigating the Factors that Influence Participation in Clinical 
Research is to accumulate enough data and information about female patients to determine factors, barriers, 
and any resources that could influence their decision to participate in clinical research. The study has three 
main aims: first is to gain a better sense of women’s general attitudes and involvements concerning clinical 
research, second the study wishes to ascertain any factors that influence female participation in clinical 
research, third the study is trying to understand the value and impact of promotional tools directed at 
creating equality in clinical research. The overall goal is to lessen or eradicate the gender disparity between 
men and women in clinical research by finally trying to find solutions to the problem. The outcomes 
indicate that pregnant and fertile women, a part of the initial data collection, are open to educational 




In 1977, the FDA issued a ban prohibiting any 
woman with “child bearing potential” from 
participating in clinical research. This ban was 
revoked in 1990, but its effects have left a lasting 
impact.
1
 Will the pregnant or fertile women 
surveyed also still be wary of clinical research 
because of this stigma? Would there be a 
difference between the motivating factors, 
barriers, and resources that influence non-fertile 
women?  
There has been a proven increase in women’s 
participation in clinical trials since the 1970s, but 
the ratio of women’s enrollment when compared 
to both the United States’ entire population and 
to diseases that impact women more frequently, 
is much lower than it should be.
2
 Since the 
beginning of 1990, different guidelines have 
tried to correct the mindset that the FDA’s ban 
created, such as the 1991 Pregnancy 
Discrimination Act and the Guideline for the 
Study and Evaluation of Gender Differences in 
the Clinical Evaluations of Drugs in 1993.
3
 In 
1994, the National Institutes of Health (NIH) 
guidelines issued by the Office of Research on 
Women’s Health and Office of Research on 
Minority Health stated that all human subjects 
must be included in research. These guidelines 
were the beginning steps bridging the gap 
between the sexes in clinical research.
2 
Guidelines continue to be imposed in the 
twentieth century. In 2003, the American Heart 
Association made separate guidelines for women 
in clinical trials.
2
 The fact is that women are 
 2 
more prone to vascular diseases, but men are 
being enrolled in drug trials much more 
frequently. The need for new strategies in 
creating gender specific medicine has become 
much more apparent. Finally, in 2012, the 
Canadian Institute of Health Research (CIHR) 
stated that all their funding applicants must 
explain whether they’re investigating gender-
related factors if their enrollment did not include 
a significant amount of women. If this is the 
case, they must explain why more women are not 
included.
2
 This will make researchers think about 
including women in their trials and could prevent 
them from excluding women without proper 
reasoning. (Many times researchers are aware of 
the increased cost and confounding factors that 
can come from including women in trials and so 
choose not to include them.) 
4 
As Kingston states in her article “Deadly Gender 
Gap”, “studying women can teach us a lot about 
the treatment of and care for chronic diseases, 
which place far more of a burden on the health 
care system.” Most importantly, the inclusion of 
pregnant women with chronic diseases can begin 
to be tested also, because sadly, most drugs used 
routinely in pregnancy have not yet been tested 
on pregnant women.”
3 
In a recent research study, the results showed 
that women can be motivated by different factors 
to participate in clinical research.
5
 Of course, 
there are still many barriers to overcome, 
especially when dealing with pregnant women or 
a woman who may become pregnant. When 
pregnant women think about taking part in a 
study, a risk to themselves, their baby, or any 
kind of required change in their behavior or 
therapy could deter them.
5
 The article, 
“Women’s Views about Participating in 
Research While Pregnant”, states that the main 
problem in surmounting these barriers is that 
“little is known about issues relevant to women 
considering research participation during 
pregnancy.”
*
 The Multicenter Study aims to 
tackle this gap head-on by becoming the first 
large-scale investigation that tries to recognize 
the opinions and factors that compel women to 





The Multicenter Study’s purpose is to be the first 
research study to investigate and come to 
conclusions about the experiences, opinions, and 
obstacles for female participation in clinical 
research. The goal is to reach out to 500 female 
patients, at least 18 years old, at each of the 
project’s sites, which include: Christiana Care, 
Columbia University, Drexel University, Lehigh 
Valley Hospital Networks (LVHN), St. Peter’s, 
and Virtua. In order to target females 
specifically, the site’s OB/GYN departments 
were the main point of distribution. The surveys 
were IRB approved and consisted of 8 pages, one 
page being designated for consent and was kept 
by the patients. The surveys were professionally 
translated in Spanish, Traditional Chinese, and 
Simplified Chinese; copies of each language 
were available at any site for use. The research 
scholars, monitored by each site’s head PI, 
administered the surveys at each of the six sites; 
the scholar was able to consent patients and 
answer any questions regarding the survey in all 
three languages when necessary. Patients were 
always informed of the anonymity and voluntary 
nature of the survey. A screening log was kept of 
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all women approached at each site. The survey 
had already been validated by another study at 
LVHN and was also circulated to 15 non-clinical 
and 15 non-research staff at LVHN asking for 
feedback. Data entry was performed by each of 
the research scholars at her perspective site. The 
results of 400 surveys given at LVHN’s sites 
were analyzed by the author. Multiple two tailed 
T-tests with confidence intervals of 95% were 










Age Range 18-76 
Pregnant 56.48% 
Not Pregnant 43.52% 
Fertile* 85.71% 
Not Fertile* 14.29% 
Participated in a Clinical Trial Previously 5.8% 
*Fertility is defined as less than 40 years in age for the purpose of this data analysis
 
by the author 
 
Table 1: General description of 400 women that participated in the survey 
 
Explanation of statistics will be referenced in Discussion and Conclusion selection below 
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For the purpose of the author’s specific data 
analysis of this initial data, the difference 
between pregnant and non-pregnant women will 
be compared, along with the differences between 
fertile and non-fertile women. These groups will 
be focused on in order to assess whether 
previous bans placed on pregnant and fertile 
women has created a lasting stigma for women, 
leading to more of a rift in the gender disparity 
related to clinical research. 
The age range of women surveyed was 18-76, 
56% of the women surveyed were pregnant when 
surveyed, and 86% of the women were fertile 
when surveyed. Fertility is defined by the author 
as less than 40 years old for the purpose of this 
analysis. Of the 400 women whose responses 
were analyzed, only about 6% of them had 
participated in a clinical trial previously. By 
looking at this summary, it is possible that, 
because of some factor, women are deterred 
from participating in clinical trials. 
When the women who had previously 
participated in clinical trials are compared, 
depending upon their fertility, there is no 
significant difference. (See figures 1 and 2). Both 
fertile women and non-fertile women seem just 
as likely to participate from their responses.  
As figure 3 shows, the women surveyed were of 
diverse racial backgrounds; this means that when 
analyzing the data, conclusions can be drawn 
about the feelings of minorities and women 
concerning influences, barriers, and helpful 
resources concerning participation in clinical 
research.  
 
When comparing the mindsets of the pregnant 
and non-pregnant women concerning factors that 
could influence their participation in clinical 
research, there was no significant difference. 
Both groups agreed that the factor, “How well 
the research is explained to me”, is the most 
important. Being offered money seemed to have 
no importance in women’s decision making 
overall, even though the average self-reported 
income was less than $30,000 a year. 
Surprisingly, even though it is hypothesized 
women may feel more comfortable being 
approached by a female doctor; the results 
seemed to show the opposite. Both pregnant and 
non-pregnant women voted “0” most often for 
this factor on the ascending scale used, meaning 
this factor was “No Motivation” to their 
participation. In this ascending scale, 0= “No 
motivation”, 1= “Very little motivation”, 2= 
“Some motivation”, 3= “Significant Motivation”, 
and 4= “Most Motivation”. 
When comparing the fertile and non-fertile 
women’s opinions of motivating factors, the only 
factor with statistically significant results is 
“Knowledge gained will benefit someone in the 
future” (p=0.0225) (see figure 6 and 7). The 
average response of a fertile woman was 2.72, 
while the average response of non-fertile women 
was 3.18. This may suggest that women who are 
not concerned about harm to their fertility can be 
motivated by altruistic circumstances. Other 
circumstances, such as these, can be looked at by 




When comparing pregnant and non-pregnant 
women, the barrier “Time commitment” was an 
important factor to both groups, with an average 
response of 2.96, but this was still less important 
in both groups than “Risk of unknown side 
effects” and “Risk to fetus/fertility” which were 
both more frequently voted as a “4” on the 
ascending scale. When comparing the responses 
of both groups, the barrier “risk to fertility/fetus” 
had statistically significant results (p=0.0004). 
The difference can be observed in figures 8 and 
9 above. It seems obvious that pregnant women 
would be more worried about their fetus or 
fertility, but this fear may have been heightened 
by past history of bad outcomes in clinical trials 
for pregnant women. This mindset makes it hard 
to enroll pregnant women in trials, and is a major 
factor that has to be overcome in order to 
continue to improve medicine for pregnant 
women and their unborn children. 
The results of the T-tests when comparing the 
same factors for fertile and non-fertile women 
were similar to the results above. The barrier 
“Risk to fetus/fertility” had very statistically 
significant findings (p=0.0133). The reasons and 
consequences of these results have already been 
discussed, but by looking at figures 10 and 11 
other interesting observations can be noted. In 
general, the non-fertile women are more 
concerned with “Risk of unknown side effects” 
than the fertile women and a little less concerned 
with “Time commitment”. An important point to 
note is that even the women classified as non-
fertile are still concerned with “Risk to 
fetus/fertility”. A large portion of the non-fertile 
women did vote this barrier as a “0” on the 
ascending scale, but 30 non-fertile women still 
voted “4” for this factor. Again, these 
observations point to some influencing factor 
that has impacted women’s mindsets, because 
this factor should be of little importance to them 
after they reach 40 years old.  
Important factors to look at are the resources that 
could help the recruitment of women. In the 
survey, six resources were provided to rate on 
the ascending scale. These resources were based 
upon original assumptions about women’s 
motivation and previous studies analyzed.
1
 
When looking at the data collected from 
pregnant and non-pregnant women, there was no 
significant difference between the opinions for 
any of the resources. The most helpful resource 
was “”Having all material provided in my own 
language” (average=2.88 for pregnant women 
and 2.91 for non-pregnant women).  The least 
important resource for these two groups of 
women was “Having access to a medical 
interpreter throughout the study”. The collective 
average for all the resources was 2.62. Figure 12 
and 13 show the similarities of the two groups of 
women’s mindsets about the resources. This 
reaffirms the hypothesis that all women and 
minorities are open to educational and supportive 
resources.  
When comparing the same data collected from 
fertile and non-fertile women, there are some 
similarities between the data discussed above 
and some statistically significant points to note. 
The data continues to indicate that “Having all 
material provided in my own language”, is the 
most important resource and “Having access to a 
medical interpreter throughout the study” is the 
least important.  
 13 
The resource, “Written material explaining the 
research study”, is significantly different when 
comparing these two groups of women. Fertile 
women (average response= 2.668) are less 
concerned with this resource than non-fertile 
women (average response= 3.063). Evaluating 
this difference (p= 0.0401) could lead to 
assuming that younger women are less 
concerned with written information, as compared 
to verbal explanations. This could imply that 
younger women are more trusting of medical 
staff, or that they are more likely to make quick 
decisions about participating. It is possible that 
older women like to think about the choice 
longer, or are less trusting.  
Surprisingly, “Having all material provided in 
the same language” has a p value of 0.0459. By 
comparing the averages, 2.83, for fertile women, 
and 3.24 for non-fertile women, it is apparent 
that the older women are more concerned with 
the language spoken to them, while the younger 
women are not as concerned. This could indicate 
that the younger women surveyed are more 
likely to speak more than one language well or 
they are more open to having research presented 
in another language, no matter the 
circumstances. This point is worth being 
researched further, because it could impact the 
way that researchers approach recruiting women 
of different ages.  
There are some limitations that could have 
confounded the data analysis. Some confounding 
factors include: unanswered questions depending 
on the participant’s comfort with certain 
questions, or the subjects’ understanding that 
another person will see their answers, even if it is 
anonymous. More confounding factors are the 
smaller sample size of “non-fertile” women, as 
compared to the fertile women, and that “non-
pregnant” and “fertile” are not mutually 
exclusive. The findings from those two groups of 
data cannot be compared to each other.  
The final findings for this small amount of data, 
looking specifically at pregnant and fertile 
women, cannot negate the hypothesis that a 
stigma has continued to impact women’s 
mindsets concerning clinical research 
participation. It seems as though pregnant, non-
pregnant, fertile, and non-fertile women are all as 
equally likely to participate in clinical research. 
These different categories of women, though, 
may respond to different tactics in order to 
recruit them. Altruism, written information, side 
effects, and the way the research is presented can 
be used to persuade each group of women 
differently and this information must be used 
accordingly. The 400 surveys pertaining to this 
author’s research cannot provide enough data to 
draw conclusive findings. After all six sites’ data 
has been collected and analyzed, final 
conclusions can be made and a course of action 




After analyzing the results of the study, it is clear 
that one kind of recruitment tactic does not work 
for all women. Further consideration must be 
made to try and change the mindset of pregnant 
women considering clinical research. Hopefully, 
this change can be made and it will have a 
positive impact on the future of research and 
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